$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 14'th Feb 2025
SAN FRANCISCO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targ
Mingzhu Receives Nasdaq Delisting Notice Subject to Hearing Request
04:00pm, Friday, 14'th Feb 2025
SHENZHEN, China , Feb. 14, 2025 /PRNewswire/ -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (Nasdaq: YGMZ ), an elite provider of logistics and transportation services to business
Nasdaq 100 and S&P 500: Tech Sector Strong as Apple and Super Micro Surge
11:32am, Friday, 14'th Feb 2025
US indices hold weekly gains as inflation fears ease. Apple soars 6%, boosting tech stocks, while investors focus on Fed policy and trade updates.
ConnectM Announces Receipt of Notice from Nasdaq That ConnectM has Regained Compliance with Nasdaq Rule
09:55am, Friday, 14'th Feb 2025
MARLBOROUGH, Mass. , Feb. 14, 2025 /PRNewswire/ -- ConnectM Technology Solutions, Inc. (Nasdaq: CNTM) ("ConnectM" or the "Company"), a technology company focused on the electrification economy, had pr
Phoenix Motor Regains Compliance with Nasdaq Listing
08:00am, Friday, 14'th Feb 2025
ANAHEIM, CA / ACCESS Newswire / February 14, 2025 / Phoenix Motor Inc. ( NASDAQ:PEV ), a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicle
2 Nasdaq Stocks That Are No-Brainer Buys Now
07:00am, Friday, 14'th Feb 2025
The tech-heavy Nasdaq index has been a great place to look for stocks with immense upside. Tech stocks have gone mostly straight up since the start of 2023, and with how much money is flowing into the
Nasdaq 100: Robinhood and Coinbase Surge on Crypto Boom—Will the Rally Extend on Friday?
04:49pm, Thursday, 13'th Feb 2025
Robinhood, Coinbase, and Roku surge post-earnings, fueling after-hours gains. Will these moves push the S&P 500 and Nasdaq higher on Friday?
GCL and RF Acquisition Corp. Have Closed the Business Combination on February 13, 2025. GCL's Ordinary Shares and Warrants Will Begin Trading on Nasdaq on February 14, 2025, Under Ticker Symbols “GC
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Thursday, 13'th Feb 2025
BRISBANE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on February 8, 2025, the Compensation Committee granted inducement awards consisting of
ConnectM Announces Receipt of Notice from Nasdaq That ConnectM has Regained Compliance with Nasdaq Rule
04:01pm, Thursday, 13'th Feb 2025
MARLBOROUGH, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ConnectM Technology Solutions, Inc. (Nasdaq: CNTM) (“ConnectM” or the “Company”), a technology company focused on the electrification econ
Nasdaq Surges 150 Points; Cisco Earnings Top Views
12:36pm, Thursday, 13'th Feb 2025
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Thursday.
LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
10:35am, Thursday, 13'th Feb 2025
PASADENA, CALIF., Feb. 13, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today annou
Codere Online Granted Listing Extension by Nasdaq and to Release Q4-24 Earnings on February 20th
09:00am, Thursday, 13'th Feb 2025
Luxembourg, Grand Duchy of Luxembourg, February 13, 2025 (GLOBE NEWSWIRE) – Codere Online Luxembourg, S.A. (Nasdaq: CDRO / CDROW) (the “Company” or “Codere Online”), a leading online gaming
Banzai Fully Regains Compliance with Nasdaq Continued Listing Requirements
08:31am, Thursday, 13'th Feb 2025
SEATTLE, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Banzai International, Inc. (Nasdaq: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and s
Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
07:00am, Thursday, 13'th Feb 2025
TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therape
Sign In
Buy NDAQ